Aarhus University logo
Meetings, symposia, a royal visit, and new building facilities. The year 2022 was eventful for DANDRITE and its researchers.
With this video, DANDRITE wishes you all a Merry Christmas and a Happy New Year.
The Lundbeck Foundation fuels young neuroscientist's biotech vision with a DKK 5 million grant from its new Frontier Grant programme. Lasse Reimer of DANDRITE at Aarhus University will spend the next 18 months bringing the promising project to maturity and taking it out of the lab in search of investors.
“For the first time, I can actually say that I believe we could do a giant breakthrough for the entire field and hopefully change the lives of millions of people struggling with Parkinson’s disease”.
The scientific presentations of this season's Internal Meetings were on display when all at DANDRITE met on Thursday 8 December. Seven young and established researchers presented their poster to colleagues who represented the judging jury of who should win this year's DANDRITE Poster Prize.
Even though it was a close tie, Postdoc Lasse Reimer from Jensen Group won the prize for his poster with the title: "SERCA as a preclinical disease modifying drug target against α-synuclein aggregate dependent dysfunctions". The prize includes 3.000 Danish Kroner to use for a scientific event.
We received the news of Marco Capogna’s passing with immense grief and sorrow. He was a most highly valued friend and colleague at DANDRITE and in true meaning an inspiration to us all.
Page 3 of 76.
Members of the Nordic EMBL Partnership for Molecular Medicine will be hosted in Helsinki in 2023 for the Annual Meeting. Program and more information…
Page 3 of 3.
The Nordic EMBL Partnership was awarded funding from NordForsk as part of its Partnership Hub Infrastructure call. The funding is designed to help increase knowledge transfer and interactions across the Nordic EMBL Partnership.
The Nordic EMBL Partnership for Molecular Medicine, where DANDRITE is the Danish node, is one of EMBL's partnerships, aiming to leverage the EMBL model together with the strengths of the partners, to create an interlinked system of excellent institutions that enhance molecular life science in Europe and the world.